메뉴 건너뛰기




Volumn 41, Issue 5, 2002, Pages 447-451

Phytotherapy. Current evidence-based evaluation;Phytotherapie bei BPH. Aktuelle evidenzbasierte bewertung

Author keywords

Benign prostatic hyperplasia; Evidence based medicine; Lower Urinary Tract Symptoms (LUTS); Phytotherapy

Indexed keywords

AZUPROSTAT; CERNITIN; CUCURBITA PEPO EXTRACT; CURBICIN; HYPOXIS ROOPERI EXTRACT; PHYTOSTEROL; PICEA EXTRACT; PINUS EXTRACT; PLANT EXTRACT; PROSTAGUTT FORTE; PYGEUM AFRICANUM EXTRACT; SABAL EXTRACT; SECALE CEREALE EXTRACT; SITOSTEROL; UNCLASSIFIED DRUG; URTICA DIOICA EXTRACT;

EID: 0036933547     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-002-0234-y     Document Type: Article
Times cited : (20)

References (36)
  • 1
    • 0032731677 scopus 로고    scopus 로고
    • Management of the BPH syndrome in Germany: Who is treated and how?
    • Berges RR, Pientka L (1999) Management of the BPH syndrome in Germany: Who is treated and how? Eur Urol 36 [Suppl 3]: 21-27
    • (1999) Eur Urol , vol.36 , Issue.SUPPL. 3 , pp. 21-27
    • Berges, R.R.1    Pientka, L.2
  • 2
    • 0032746298 scopus 로고    scopus 로고
    • Introduction and concluding remarks
    • Chapple CR (1999) Introduction and concluding remarks. Eur Urol 36 [Suppl 3]: 1-6
    • (1999) Eur Urol , vol.36 , Issue.SUPPL. 3 , pp. 1-6
    • Chapple, C.R.1
  • 3
    • 0028921373 scopus 로고
    • Stellenwert von phytotherapeutika bei der behandlung der benignen prostatahyperplasie (BPH)
    • Dreikorn K, Schönhöfer PS (1995) Stellenwert von Phytotherapeutika bei der Behandlung der benignen Prostatahyperplasie (BPH). Urologe A 34: 119-129
    • (1995) Urologe A , vol.34 , pp. 119-129
    • Dreikorn, K.1    Schönhöfer, P.S.2
  • 5
    • 0034256274 scopus 로고    scopus 로고
    • Phytotherapeutic agents in the treatment of benign prostatic hyperplasia
    • Dreikorn K (2000) Phytotherapeutic agents in the treatment of benign prostatic hyperplasia. Curr Urol Rep 1: 103-109
    • (2000) Curr Urol Rep , vol.1 , pp. 103-109
    • Dreikorn, K.1
  • 6
    • 0012367238 scopus 로고    scopus 로고
    • The medical management of BPH with agents oterh than hormones or alpha-blockers
    • Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds). Monaco, June 26-28 1995 S.C.I.
    • Fitzpatrick JM, Braeckman J, Denis L et al. (1996) The medical management of BPH with agents oterh than hormones or alpha-blockers. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds) Proceedings of the 3rd International Consulation on benign prostatic hyperplasia (BPH). Monaco, June 26-28 1995 S.C.I. pp 489-494
    • (1996) Proceedings of the 3rd International Consulation on Benign Prostatic Hyperplasia (BPH) , pp. 489-494
    • Fitzpatrick, J.M.1    Braeckman, J.2    Denis, L.3
  • 7
    • 0000435965 scopus 로고    scopus 로고
    • Phytotherapeutic agents
    • Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P (eds). Isis Medical Media, Oxford
    • Fitzpatrick JM, Lynch TH (1996) Phytotherapeutic agents. In: Kirby R, McConnell JD, Fitzpatrick JM, Roehrborn CG, Boyle P (eds) Textbook of Benign Prostatic Hyperplasia. Isis Medical Media, Oxford, pp 331-337
    • (1996) Textbook of Benign Prostatic Hyperplasia , pp. 331-337
    • Fitzpatrick, J.M.1    Lynch, T.H.2
  • 8
    • 0029859371 scopus 로고    scopus 로고
    • Serenoa repens (Permixon): A review of its Pharmacology and therapeutic efficacy in benign prostatic hyperplasia
    • Plosker GL, Brogden RN (1996) Serenoa repens (Permixon): A review of its Pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging 9: 379-395
    • (1996) Drugs Aging , vol.9 , pp. 379-395
    • Plosker, G.L.1    Brogden, R.N.2
  • 9
    • 0012402270 scopus 로고    scopus 로고
    • Analytische charakterisierung von sabalextrakten und sabalzubereitungen in Europa und in USA
    • 18-19.05. Bad Neuenaar
    • Kurth H, Glasmacher F, Gaedcke F (2000) Analytische Charakterisierung von Sabalextrakten und Sabalzubereitungen in Europa und in USA. 3. Finzelbergsymposium, 18-19.05. Bad Neuenaar
    • (2000) Finzelbergsymposium , vol.3
    • Kurth, H.1    Glasmacher, F.2    Gaedcke, F.3
  • 10
    • 0029066391 scopus 로고    scopus 로고
    • Placebo-controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after exclusion of placebo responders
    • Descotes JL, Rambeaud JJ, Deschaseaux P, Faure G (1996) Placebo-controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after exclusion of placebo responders. Clin Drug Invest 9: 291-297
    • (1996) Clin Drug Invest , vol.9 , pp. 291-297
    • Descotes, J.L.1    Rambeaud, J.J.2    Deschaseaux, P.3    Faure, G.4
  • 11
    • 0012435601 scopus 로고    scopus 로고
    • Randomized, double blind, placebo-controlled study of saw palmetto in men with lower urinary tract symtoms (LUTS)
    • Kuznetsow DD, Gerber GS, Burstein JD (2001) Randomized, double blind, placebo-controlled study of saw palmetto in men with lower urinary tract symtoms (LUTS). J Urol 165: 263
    • (2001) J Urol , vol.165 , pp. 263
    • Kuznetsow, D.D.1    Gerber, G.S.2    Burstein, J.D.3
  • 12
    • 0347318854 scopus 로고    scopus 로고
    • Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostatic hyperplasia: A randomized international study of 1.089 patients
    • Carraro JC, Raynaud JP, Koch G et al. (1996) Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostatic hyperplasia: a randomized international study of 1.089 patients. Prostate 29: 231-240
    • (1996) Prostate , vol.29 , pp. 231-240
    • Carraro, J.C.1    Raynaud, J.P.2    Koch, G.3
  • 13
    • 0012470488 scopus 로고    scopus 로고
    • Phytotherapy (LSESR) vs an αblocker for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: A randomized comparative study
    • Debruyne F (2001) Phytotherapy (LSESR) vs an αblocker for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: A randomized comparative study. J Urol 165 (5): 381-382
    • (2001) J Urol , vol.165 , Issue.5 , pp. 381-382
    • Debruyne, F.1
  • 14
    • 0029078027 scopus 로고
    • Randomised, placebo-controlled, double blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia
    • Berges RR, Windeler J, Trampisch H et al. (1995) Randomised, placebo-controlled, double blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Lancet 345: 1529-1532
    • (1995) Lancet , vol.345 , pp. 1529-1532
    • Berges, R.R.1    Windeler, J.2    Trampisch, H.3
  • 15
    • 0034052168 scopus 로고    scopus 로고
    • Treatment of symptomatic benign prostatic hyperplasia with â-sitosterol: An 18-month follow-up
    • Berges RR, Kassen A, Senge T (2000) Treatment of symptomatic benign prostatic hyperplasia with â-sitosterol: an 18-month follow-up. BJU Int 85: 842-846
    • (2000) BJU Int , vol.85 , pp. 842-846
    • Berges, R.R.1    Kassen, A.2    Senge, T.3
  • 16
    • 0031398916 scopus 로고    scopus 로고
    • A multicentric, placebo-controlled, double-blind clinical trial of β-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia
    • Klippel KF, Hiltl D-M, Schipp B (1997) A multicentric, placebo-controlled, double-blind clinical trial of β-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. Br J Urol 80: 427-432
    • (1997) Br J Urol , vol.80 , pp. 427-432
    • Klippel, K.F.1    Hiltl, D.-M.2    Schipp, B.3
  • 17
    • 0031671309 scopus 로고    scopus 로고
    • Efficacy and acceptability of Tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): A multicentre trial in Central Europe
    • Breza J, Dziurny O, Borowka A, et al (1998) Efficacy and acceptability of Tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): A multicentre trial in Central Europe. Curr Med Res Opin 3: 127-139
    • (1998) Curr Med Res Opin , vol.3 , pp. 127-139
    • Breza, J.1    Dziurny, O.2    Borowka, A.3
  • 18
    • 0033119883 scopus 로고    scopus 로고
    • Phytotherapyin the treatment of benign prostatic hyperplasia: An update
    • Lowe FC, Fagelman E (1999) Phytotherapyin the treatment of benign prostatic hyperplasia: an update. Urology 53: 671-678
    • (1999) Urology , vol.53 , pp. 671-678
    • Lowe, F.C.1    Fagelman, E.2
  • 19
    • 0030430231 scopus 로고    scopus 로고
    • Phytotherapy for the prostate
    • Buck AC (1996) Phytotherapy for the prostate. Br J Urol 78: 325-336
    • (1996) Br J Urol , vol.78 , pp. 325-336
    • Buck, A.C.1
  • 20
    • 0002229222 scopus 로고
    • Phytotherapie der benignen prostatahyperplasie: Doppelblindstudie mit extractum radicis urticae (ERU)
    • Dathe G, Schmid H (1987) Phytotherapie der benignen Prostatahyperplasie: Doppelblindstudie mit Extractum Radicis Urticae (ERU). Urologe B 27: 233-226
    • (1987) Urologe B , vol.27 , pp. 233-226
    • Dathe, G.1    Schmid, H.2
  • 21
    • 0021919879 scopus 로고
    • Ergebnisse einer doppelblindstudie über die wirksamkeit von ERU-Kapseln in der konservativen behandlung der benignen prostatahyperplasie
    • Vontobel HP, Herzog R, Rutishauser GH (1985) Ergebnisse einer Doppelblindstudie über die Wirksamkeit von ERU-Kapseln in der konservativen Behandlung der benignen Prostatahyperplasie. Urologe A 24: 49-51
    • (1985) Urologe A , vol.24 , pp. 49-51
    • Vontobel, H.P.1    Herzog, R.2    Rutishauser, G.H.3
  • 22
    • 0029815804 scopus 로고    scopus 로고
    • Therapie der benignen prostatahyperplasie mit bazoton liquidum
    • Engelmann U, Boos G, Kres H (1996) Therapie der benignen Prostatahyperplasie mit Bazoton Liquidum. Urologe B 36: 287-291
    • (1996) Urologe B , vol.36 , pp. 287-291
    • Engelmann, U.1    Boos, G.2    Kres, H.3
  • 23
    • 0023691102 scopus 로고
    • Konservative therapie der benignen prostatahyperplasie (BPH) mit cernilton
    • Becker H, Ebeling L (1988) Konservative Therapie der benignen Prostatahyperplasie (BPH) mit Cernilton. Urologe B 28: 301-306
    • (1988) Urologe B , vol.28 , pp. 301-306
    • Becker, H.1    Ebeling, L.2
  • 24
    • 0025119848 scopus 로고
    • Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract Cernilton
    • Buck AC, Cox R, Rees RWM et al. (1990) Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract Cernilton. Br J Urol 66: 398-404
    • (1990) Br J Urol , vol.66 , pp. 398-404
    • Buck, A.C.1    Cox, R.2    Rees, R.W.M.3
  • 25
    • 0029984815 scopus 로고    scopus 로고
    • Usefulness of Cernilton in the treatment of benign prostatic hyperplasia
    • Dutkiewicz S (1996) Usefulness of Cernilton in the treatment of benign prostatic hyperplasia. Int Urol Nephrol 28: 49-53
    • (1996) Int Urol Nephrol , vol.28 , pp. 49-53
    • Dutkiewicz, S.1
  • 26
    • 0033789446 scopus 로고    scopus 로고
    • Placebokontrollierte langzeittherapiestudie mit kürbissamenextrakt bei BPH-bedingten miktionsbeschwerden
    • Bach D (2000) Placebokontrollierte Langzeittherapiestudie mit Kürbissamenextrakt bei BPH-bedingten Miktionsbeschwerden. Urologe B 40: 437-443
    • (2000) Urologe B , vol.40 , pp. 437-443
    • Bach, D.1
  • 27
    • 0025603727 scopus 로고
    • Treatment of benign prostatic hyperplasia with phytosterols
    • Carbin BE, Larsson B, Lindahl O (1990) Treatment of benign prostatic hyperplasia with phytosterols. Br J Urol 66: 639-641
    • (1990) Br J Urol , vol.66 , pp. 639-641
    • Carbin, B.E.1    Larsson, B.2    Lindahl, O.3
  • 28
    • 0029842385 scopus 로고    scopus 로고
    • Wirksamkeit eines sabal-urtica-kombinationspräparates bei der behandlung der benignen prostatahyperplasie (BPH)
    • Metzker M, Kieser M, Hölscher U (1996) Wirksamkeit eines Sabal-Urtica-Kombinationspräparates bei der Behandlung der benignen Prostatahyperplasie (BPH). Urologe B 36: 292-300
    • (1996) Urologe B , vol.36 , pp. 292-300
    • Metzker, M.1    Kieser, M.2    Hölscher, U.3
  • 29
    • 0030805911 scopus 로고    scopus 로고
    • Kombination aus sabalund urticaextrakt mit finasterid bei BPH (Stad.bis II nach Alken)
    • Sökeland J, Albrecht J (1997) Kombination aus Sabalund Urticaextrakt mit Finasterid bei BPH (Stad.bis II nach Alken). Urologe A 36: 327-333
    • (1997) Urologe A , vol.36 , pp. 327-333
    • Sökeland, J.1    Albrecht, J.2
  • 30
    • 1842376945 scopus 로고    scopus 로고
    • Discrepancies between meta-analyses and subsequent large randomised, controlled trials
    • LeLorier J, Grégoire G, Benhaddad A et al. (1997) Discrepancies between meta-analyses and subsequent large randomised, controlled trials. N Engl J Med 337: 536-542
    • (1997) N Engl J Med , vol.337 , pp. 536-542
    • LeLorier, J.1    Grégoire, G.2    Benhaddad, A.3
  • 31
    • 0034058050 scopus 로고    scopus 로고
    • Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia
    • Boyle P, Lowe F, Robertson C, Roehrborn CG (2000) Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 55: 533-539
    • (2000) Urology , vol.55 , pp. 533-539
    • Boyle, P.1    Lowe, F.2    Robertson, C.3    Roehrborn, C.G.4
  • 32
    • 0032508943 scopus 로고    scopus 로고
    • Saw palmetto extracts for treatment of benign prostatic hyperplasia: A systematic review
    • Wilt TJ, Ishani A, Stark G et al. (1998) Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 280: 1604-1609
    • (1998) JAMA , vol.280 , pp. 1604-1609
    • Wilt, T.J.1    Ishani, A.2    Stark, G.3
  • 33
    • 0033049121 scopus 로고    scopus 로고
    • â-sitosterol for the treatment of benign prostatic hyperplasia: A systematic review
    • Wilt TJ, McDonald R, Ishani A (1999) â-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU Int 83: 976-983
    • (1999) BJU Int , vol.83 , pp. 976-983
    • Wilt, T.J.1    McDonald, R.2    Ishani, A.3
  • 34
    • 0034052603 scopus 로고    scopus 로고
    • Asystematic review of Cernilton for the treatment of benign prostatic hyperplasia
    • MacDonald R, Ishani A, Rutks I et al. (2000) Asystematic review of Cernilton for the treatment of benign prostatic hyperplasia. BJU Int 85: 836-841
    • (2000) BJU Int , vol.85 , pp. 836-841
    • MacDonald, R.1    Ishani, A.2    Rutks, I.3
  • 35
    • 0034563896 scopus 로고    scopus 로고
    • Pygeum Africanum for the treatment of patients with benign prostatic hyperplasia: A systematic review and quantitative metaanalysis
    • Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ (2000) Pygeum Africanum for the treatment of patients with benign prostatic hyperplasia: A systematic review and quantitative metaanalysis. Am J Med 109: 654-664
    • (2000) Am J Med , vol.109 , pp. 654-664
    • Ishani, A.1    MacDonald, R.2    Nelson, D.3    Rutks, I.4    Wilt, T.J.5
  • 36
    • 0036549740 scopus 로고    scopus 로고
    • The role of phytotherapy in treating lower urinary tract symptoms and benign prostetic hyperplasia
    • Dreikorn K (2002) The role of phytotherapy in treating lower urinary tract symptoms and benign prostetic hyperplasia. World J Urol 19: 426-435
    • (2002) World J Urol , vol.19 , pp. 426-435
    • Dreikorn, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.